First Advantage Introduces Next-Gen RightID™ to Detect Job Applicant Fraud in Pre-Hire Process
ATLANTA, March 11, 2024 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, […]
UP Fintech Holding Limited to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024
SINGAPORE, March 11, 2024 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading […]
Recursion Announces Plans to Open New Office in London
LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize […]
ASML publishes agenda Annual General Meeting 2024
ASML publishes agenda Annual General Meeting 2024 Veldhoven, the Netherlands, March 11, 2024 – Today, ASML Holding NV (ASML) has […]
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a […]
VCI Global Limited Establishes Support For Wisdom Accelerator Youth (WAY) Alongside The World Economic Forum
KUALA LUMPUR, Malaysia, March 10, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) is poised to make a profound […]
United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
Investigational roflumilast cream 0.05% met the primary endpoint and all secondary endpoints, showing significant improvement across multiple efficacy endpoints as […]
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
Findings show that seborrheic dermatitis is a unique inflammatory skin disease with its own molecular signature Suggests skin barrier disruption […]
Linde plc to Join the Nasdaq-100 Index® Beginning March 18, 2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Linde plc (Nasdaq: LIN), will become […]
